Option chain shows key data for Biolife Sciences's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Biolife Sciences.

Biolife Sciences (OTC:BLFE) Stock, Option Chain

Biolife Sciences Inc is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors. The company's technologies include antimicrobial copper air filters and copper-infused textiles. Its revenues are primarily generated from the sale of sanitation products.

Biotech

News

Penny Stocks

Rumors

Commodities

Small Cap

Markets

General

BLFE

HENDERSON, NV, Aug 10, 2022 – BioLife Sciences Inc. (BioLife), a commercialization accelerator, licensor and developer of technologies, has reportedly provided investors with a significant company update throughout the course of a two-year transformation.

Is BioLife Sciences (OTCPK: BLFE) An OTC Company Primed For Growth?

Cannabis

Press Releases

BioLife Sciences (OTCPK: BLFE), a firm dedicated to developing, licensing, and distributing antimicrobial products and disruptive technologies, announced on Tuesday that it is expanding its recently announced orthomolecular medicine and natural health products department to now include a subsector dedicated to non-psychoactive cannabinoids derived from industrial hemp, includin

BioLife Sciences Inc. To Incorporate New Sub-Sector Dedicated To CBD

BIOLIFE SCIENCES INC by BIOLIFE SCIENCES INC.

Comments

Biolife Sciences

Biolife Sciences (BLFE) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell